Research interests
• Protein-protein interactions
• Molecular mechanism of neurodegenerative diseases (ALS, FTD)
• Stress granules formation in relation to ALS
• Pathology of RNA binding proteins in ALS and FTD

Research experience and education
2025: Visiting Graduate Researcher, London Neurodegenerative Disease Brain Bank, King’s College London, London, United Kingdom
2022 – : PhD junior researcher, Department of Biotechnology, Jožef Stefan Institute, Ljubljana, Slovenia /PhD student , Interdisciplinary doctoral programme Biomedicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
2022: Associate, Department of Biotechnology, Jožef Stefan Institute, Ljubljana, Slovenia
2019 – 2021: MSc, Biochemistry, Faculty of Chemistry and Chemical Technology, University of Ljubljana, Slovenia
2016 – 2019: BSc, Biochemistry, Faculty of Chemistry and Chemical Technology, University of Ljubljana, Slovenia

Awards and fellowships
• 2026: Best Young Researcher Talk Award at the 2nd ICGEB Symposium on Inflammation and Proteinopathy in ALS/FTD
• 2026: ICGEB travel grant for participation in the 2nd ICGEB Symposium on Inflammation and Proteinopathy in ALS/FTD
• 2025: SiNAPSA scholarship for a short exchange at King’s College London, United Kingdom, in October 2025
• 2025: FENS Summer Fellowship for an exchange at the Brain Bank, King’s College London, United Kingdom, during the summer 2025
• 2025: ICGEB travel grant for participation in the Arturo Falaschi Conference “2nd biennial conference on TDP-43 function and dysfunction in disease”
• 2024: SiNAPSA scholarship for participation in ENCALS 2024
• 2024: IBRO-PERC travel grant for participation in FENS Forum 2024
• 2023: ICGEB travel grant for participation in the Arturo Falaschi Conference “1st biennial conference on TDP-43 function and dysfunction in disease”
• 2023: SBD scholarship for participation in ENCALS 2023
• 2022: EMBO travel grant for participation in the “RNA meets protein decay” workshop
• 2022: ICGEB travel grant for participation in “Inflammation and proteinopathy in ALS/FTD spectrum disorder: joint ICGEB and ALS Society of Canada Symposium”